Enzymatically Inactive Tissue-Type Plasminogen Activator Reverses Disease Progression in the Dextran Sulfate Sodium Mouse Model of Inflammatory Bowel Disease-Reference-Cited by-同舟云学术

Enzymatically Inactive Tissue-Type Plasminogen Activator Reverses Disease Progression in the Dextran Sulfate Sodium Mouse Model of Inflammatory Bowel Disease

Published:2021-04 Issue:4 Volume:191 Page:590-601
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Das Lipsa^ORCID,Banki Michael A.^ORCID,Azmoon Pardis^ORCID,Pizzo Donald^ORCID,Gonias Steven L.^ORCID

Funder

Foundation for the National Institutes of Health

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference49 articles.

1. Immunopathogenesis of IBD: current state of the art;De Souza;Nat Rev Gastroenterol Hepatol,2016

2. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease;Hugot;Nature,2001

3. The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions;Vindigni;Therap Adv Gastroenterol,2016

4. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment;Morgan;Genome Biol,2012

5. The microbiome in inflammatory bowel disease: current status and the future ahead;Kostic;Gastroenterology,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. D-Amino acids from foods and gut microbiota and their effects in health and disease;Food Reviews International;2024-05-30

2. An LRP1-binding motif in cellular prion protein replicates cell-signaling activities of the full-length protein;JCI Insight;2023-08-08

3. An antibody that targets cell‐surface glucose‐regulated protein‐78 inhibits expression of inflammatory cytokines and plasminogen activator inhibitors by macrophages;Journal of Cellular Biochemistry;2023-03-22

4. The LRP1/CD91 ligands, tissue-type plasminogen activator, α2-macroglobulin, and soluble cellular prion protein have distinct co-receptor requirements for activation of cell-signaling;Scientific Reports;2022-10-20

5. α1‐Antitrypsin derived SP16 peptide demonstrates efficacy in rodent models of acute and neuropathic pain;The FASEB Journal;2021-12-09